ifosfamide and urea
ifosfamide has been researched along with urea in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ardenne, M; Reitnauer, PG | 1 |
| Durnov, LA; Kasumov, ChM; Kumykova, ZhKh; Kushlinskiĭ, NE; Liubimova, NV | 1 |
| Alexander, JP; Cravatt, BF | 1 |
| Morlock, GE; Yüce, I | 1 |
| Boskabadi, J; Salehifar, E; Yousefi-Mazhin, E | 1 |
Other Studies
6 other study(ies) available for ifosfamide and urea
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Demonstration of tumor inhibiting properties of a strongly immunostimulating low-molecular weight substance. Comparative studies with ifosfamide on the immuno-labile DS carcinosarcoma. Stimulation of the autoimmune activity for approx. 20 days by BA 1, a
Topics: Animals; Antineoplastic Agents; Carcinosarcoma; Cyclophosphamide; Drug Evaluation, Preclinical; Drug Tolerance; Erythrocyte Count; Hydrogen-Ion Concentration; Hyperglycemia; Ifosfamide; Immunity; Immunosuppression Therapy; Lethal Dose 50; Leukocyte Count; Male; Mice; Neoplasms, Experimental; Rats; Stimulation, Chemical; Time Factors; Urea | 1975 |
[Biochemical parameters in the diagnosis of nephrotoxicity of antineoplastic chemotherapy in children].
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Cisplatin; Creatinine; Female; Humans; Ifosfamide; Male; Neoplasms; Renal Insufficiency; Urea | 1997 |
The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases.
Topics: Amidohydrolases; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Brain; Cannabinoid Receptor Modulators; Carbamates; Cisplatin; Endocannabinoids; Gene Deletion; Heterocyclic Compounds, 1-Ring; Hydrolases; Ifosfamide; Male; Mice; Mice, Inbred C57BL; Mitomycin; Molecular Structure; Urea | 2006 |
All on one high-performance thin-layer chromatography plate: solvent-free nanomole-scaled on-surface synthesis, workup and online high-resolution mass spectrometry for elucidation of two new degradation products in an ifosfamide formulation.
Topics: Amines; Chromatography, Thin Layer; Densitometry; Drug Compounding; Drug Contamination; Ifosfamide; Magnetic Resonance Spectroscopy; Mass Spectrometry; Urea | 2018 |
Ifosfamide-induced acute kidney injury in a patient with leiomyosarcoma: A case report.
Topics: Acetylcysteine; Acute Kidney Injury; Creatinine; Female; Humans; Ifosfamide; Leiomyosarcoma; Mesna; Urea | 2022 |